Template:Cite journal: Difference between revisions
Appearance
	
	
Technician (talk | contribs) No edit summary  | 
				Technician (talk | contribs) No edit summary  | 
				||
| Line 4: | Line 4: | ||
-->|{{{vauthors}}}{{#if: {{{date|}}} | ({{{date}}})}}.<nowiki> </nowiki><!--  | -->|{{{vauthors}}}{{#if: {{{date|}}} | ({{{date}}})}}.<nowiki> </nowiki><!--  | ||
-->|{{#if: {{{last|}}} |{{{last}}}, {{{first}}}}}<!--  | -->|{{#if: {{{last|}}} |{{{last}}}, {{{first}}}}}<!--  | ||
 -->{{#if: {{{last1|}}} |{{{last1}}}, {{{first1}}}}}<!--  | |||
  -->{{#if: {{{last2|}}} |<nowiki>;</nowiki> {{{last2}}}, {{{first2}}}}}<!--  |   -->{{#if: {{{last2|}}} |<nowiki>;</nowiki> {{{last2}}}, {{{first2}}}}}<!--  | ||
  -->{{#if: {{{last3|}}} |<nowiki>;</nowiki> {{{last3}}}, {{{first3}}}}}<!--  |   -->{{#if: {{{last3|}}} |<nowiki>;</nowiki> {{{last3}}}, {{{first3}}}}}<!--  | ||
  -->{{#if: {{{last4|}}} |<nowiki>;</nowiki> {{{last4}}}, {{{first4}}}}}<!--  |   -->{{#if: {{{last4|}}} |<nowiki>;</nowiki> {{{last4}}}, {{{first4}}}}}<!--  | ||
  -->{{#if: {{{last5|}}} |<nowiki>;</nowiki> {{{last5}}}, {{{first5}}}}}<!--  |   -->{{#if: {{{last5|}}} |<nowiki>;</nowiki> {{{last5}}}, {{{first5}}}}}<!--  | ||
  -->{{#if: {{{date|}}} | ({{{date}}})}}.<nowiki> </nowiki><!--  |   -->{{#if: {{{last|}}} {{{last1|}}} | {{#if: {{{date|}}} | ({{{date}}})}}.}}<nowiki> </nowiki><!--  | ||
-->}}<!--  | -->}}<!--  | ||
Latest revision as of 20:52, 30 May 2019
View source to see examples of use.
- Bannen R, Suresh V, Phillips GN Jr, Wright S, Mitchell J (2008). "Optimal design of thermally stable proteins". Bioinformatics. 24 (20): 2339–2343. doi:10.1093/bioinformatics/btn450. PMC 2562006. PMID 18723523.
 - Bannen, RM; Suresh, V; Phillips, GN Jr; Wright, SJ; Mitchell, JC (2008). "Optimal design of thermally stable proteins". Bioinformatics. 24 (20): 2339–2343. doi:10.1093/bioinformatics/btn450. PMC 2562006. PMID 18723523.
 - Viollet, Benoît; Andreelli, Fabrizio; Jørgensen, Sebastian B.; Perrin, Christophe; Geloen, Alain (January 2003). "The AMP-activated protein kinase α2 catalytic subunit controls whole-body insulin sensitivity". The Journal of Clinical Investigation. 111 (1): 91–98. doi:10.1172/JCI16567. PMC 151837. PMID 12511592. Retrieved 2012-11-17.
 - Viollet, Benoît; Andreelli, Fabrizio; Jørgensen, Sebastian B.; Perrin, Christophe; Geloen, Alain (January 2003). "The AMP-activated protein kinase α2 catalytic subunit controls whole-body insulin sensitivity". The Journal of Clinical Investigation. 111 (1): 91–98. doi:10.1172/JCI16567. PMC 151837. PMID 12511592.